New semi-automated sample method facilities extraction of urine samples for LC-MS/MS analysis

INTEGRA, in conjunction with DPX Labs LLC, has produced an application note that describes a novel high throughput semi-automated sample method for processing urine samples ready for drugs of abuse analysis by LC-MS/MS.

Using an INTEGRA VIAFLO 96 electronic pipette with DPX mixed mode tips, a single 96-well plate loaded with samples can be extracted and ready for LC-MS/MS analysis in less than ten minutes eliminating the need for a time-consuming evaporation step.

Sample preparation is required to remove matrix interferences from urine samples prior to LC-MS/MS analysis. This procedure is typically very time-consuming and is generally the “bottleneck” for laboratory analysis. DPX extraction is a highly reproducible and sensitive dispersive SPE method that requires much less solvent compared to other SPE techniques.

The application note describes how an INTEGRA VIAFLO 96 electronic pipette was used to simultaneously undertake, in each well of a 96-well plate, the various steps of the DPX protocol (analyte binding, resin washing, analyte elution). Results from this semi-automated method are shown to be linear, accurate, and reproducible. All correlation coefficients for the protocol were greater than 0.99 for the range of 12.5 – 400 ng/mL.

The INTEGRA VIAFLO 96 is a handheld 96-channel electronic pipette that enables fast, precise and easy simultaneous transfer of 96 samples from microplates without the cost of a fully automated system. The VIAFLO 96 requires no special skills or training to operate it. Fast replication or reformatting of 96-well plates and high precision transferring of reagents, compounds and solutions to or from microplates with the VIAFLO 96 is as easy as pipetting with a standard electronic pipette into a single tube. Four pipetting heads with pipetting volumes up to 12.5 µl, 125 µl, 300 µl or 1250 µl are available for the VIAFLO 96. These pipetting heads are interchangeable within seconds enabling optimal matching of the available volume range to the application performed.

Source: http://www.integra-biosciences.com/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    INTEGRA Biosciences. (2016, February 19). New semi-automated sample method facilities extraction of urine samples for LC-MS/MS analysis. News-Medical. Retrieved on April 26, 2024 from https://www.news-medical.net/news/20160219/New-semi-automated-sample-method-facilities-extraction-of-urine-samples-for-LC-MSMS-analysis.aspx.

  • MLA

    INTEGRA Biosciences. "New semi-automated sample method facilities extraction of urine samples for LC-MS/MS analysis". News-Medical. 26 April 2024. <https://www.news-medical.net/news/20160219/New-semi-automated-sample-method-facilities-extraction-of-urine-samples-for-LC-MSMS-analysis.aspx>.

  • Chicago

    INTEGRA Biosciences. "New semi-automated sample method facilities extraction of urine samples for LC-MS/MS analysis". News-Medical. https://www.news-medical.net/news/20160219/New-semi-automated-sample-method-facilities-extraction-of-urine-samples-for-LC-MSMS-analysis.aspx. (accessed April 26, 2024).

  • Harvard

    INTEGRA Biosciences. 2016. New semi-automated sample method facilities extraction of urine samples for LC-MS/MS analysis. News-Medical, viewed 26 April 2024, https://www.news-medical.net/news/20160219/New-semi-automated-sample-method-facilities-extraction-of-urine-samples-for-LC-MSMS-analysis.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Advancing neurotoxicity research with INTEGRA pipettes